Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT06658067
- Status
- Recruiting
Conditions
- Diabetes
- Type 2 Diabetes
- Type 2 Diabetes Mellitus - Poor Control
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Continuous Glucose Monitor (CGM) — DEVICEThe first CGM sensor will be applied as directed during the first visit with a brief training by staff. Participant will be instructed to remove and replace the device every 14 days for the remainder of the 3-month trial period. Participant will also be instructed to scan the sensor three times daily. Compliance may be tracked via remote accessing of the blood glucose log on the online FreeStyle portal. CGM models used will include the Abbott FreeStyle Libre 2 and 3 and Dexcom G5, G6 and G7.
Study Details
This non-blinded, non-randomized pre-post study will examine the impact of providing CGM sensors free of charge to adult patients of Fair Haven Community Health Care with poorly controlled type 2 diabetes on glycemic control and quality of life.
Key Dates
- Start date
- Nov 12, 2024
- Status verified
- Dec 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 17 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Poorly Controlled Type 2 Diabetes- CGMParticipants will have CGM sensor placed at first visit and will be worn for 12 weeks. Sensor must be scanned 3 times daily. Adjustments to medication regimen will be recommended at 6 weeks. Follow-up appointments will be at 12 weeks and 24 weeks.
Primary Outcome Measure
Mean Illness Intrusiveness Ratings Scale score (IIRS) [ Time Frame: Baseline, 12 weeks, 24 weeks ]
Central Contacts
- Justin A Dower, MD(973) 901-4431
- Anne Camp, MD(203) 927-6666
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Fair Haven Community Health Care (FHCHC) | New Haven | Connecticut | 06520 | - |
Find similar trials in New Haven, CT
By condition
By specialty
By research site
Related Studies
- Ultrasound Effects on Glycemic Control in T2DMRecruiting · Yale University · New Haven, Connecticut
- A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)PHASE3 · Recruiting · Eli Lilly and Company · Tucson, Arizona
- Diabetes and Heart Disease Risk in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Urinary Vitamin C Loss in Diabetic SubjectsRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland